BIBLIOGRAFIA
1) HerbalEGram: Volume 9, Number 5, May 2012
2) Chen CF1, Chiou WF, Zhang JT. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol Sin. 2008 Sep;29(9):1103-8.
3) Duda, R. B., Zhong, Y., Navas, V., Li, M. Z., Toy, B. R., & Alavarez, J. G. (1999). American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. Journal of Surgical Oncology 72 (4), 230-239.
4) Murphy, L. (2002). American ginseng in the prevention and treatment of human breast cancer. Report to U.S. Report – Carbondale, IL: Southern Illinois University.
5) Kim, H.-S., Lee, E.-H., Ko, S.-R., Choi, K.-J., Park, J.-H., & Im, D.-S. (2004). Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Archives of Pharmacal Research 27 (4), 429-435.
6) Xu, T.-M., Cui, M.-H., Xin, Y., Gu, L.-P., Jiang, X., Su, M.-M., Wang, D.-D., & Wang, W.-J. (2008). Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chinese Medical Journal 121 (15), 1394-1397.
7) King, M. L. & Murphy, L. L. (2007). American ginseng (Panax quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7 cells. Journal of Experimental Therapeutics & Oncology 6 (2), 147-155.
8) Barton, D. L., Soori, G. S., Bauer, B. A., Sloan, J. A., Johnson, P. A., Figueras, C., Duane, S., Mattar, B., Liu, H., Atherton, P.J., Christensen, B., & Loprinzi, C.L. (2009). Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Supportive Care in Cancer 18 (2), 179-187.
9) https://studiclinici.aiom.it/studi-clinici/elenco-completo-studi-clinici/ginseng-americano-panax-quinquefolius-nella-prevenzione-della-fatigue-moderata-severa-in-pazienti-con-carcinoma-della-mammella-operate-e-sottoposte-a-/6-510-10577
10) Scholey, A., Ossoukhova, A., Owen, L., Ibarra, A., Pipingas, A., He, K., Roller, M., & Stough, C. (2010). Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology 212 (3),345-356.
11) Vuksan, V., Stavro, M. P., Sievenpiper, J. L., Beljan-Zdravkovic, U., Leiter, L. A., Josse, R. G., & Xu, Z. (2000). Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23, 9 ,1221 1226.
12) Reeds, D. N., Patterson, B. W., Okunade, A., Holloszy, J. O., Polonsky, K. S., & Klein, S. (2011). Ginseng and Ginsenoside Re Do Not Improve ?-Cell Function or Insulin Sensitivity in Overweight and Obese Subjects With Impaired Glucose Tolerance or Diabetes. Diabetes Care 34 (5),1071 -1076.
13) Babish, J. G., Pacioretty, L. M., Bland, J. S., Minich, D. M., Hu, J., & Tripp, M. L. (2010). Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice. J.Medicinal Food 13( 3), 535-547.
14) Reeds, D. N., Patterson, B. W., Okunade, A., Holloszy, J. O., Polonsky, K. S., & Klein, S. (2011). Ginseng and Ginsenoside Re Do Not Improve ?-Cell Function or Insulin Sensitivity in Overweight and Obese Subjects With Impaired Glucose Tolerance or Diabetes. Diabetes Care 34 (5),1071 -1076.
15) Yuan, C.-S., Wang, C.-Z., Wicks, S. M., & Qi, L.-W. (2010). Chemical and pharmacological studies of saponins with a focus on American ginseng. Journal of ginseng research 34 (3), 160-167.
16) Papapetropoulos, A. (2007). A ginseng-derived oestrogen receptor ? (ER?) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis. British Journal of Pharmacology 152 (2) .172-174.
17) Lee, Y. J., Chung, E., Lee, K. Y., Lee, Y. H., Huh, B, & Lee, S. K. (1997). Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Molecular and Cellular Endocrinology 133 (2),135-140.
18) Bensky, D. & Gamble, A. 1993. Chinese herbal medicine materia medica (Rev. ed.). Seattle, WA: Eastland Press.
19) National Toxicology Program. (2004). Summary of Data for Ginseng and Ginsenosides 5067080-0, vol. 2004. Washington, DC: National Toxicology Program, National Institute of Health
20) Luu, A., Foster, B. C., McIntyre, K. L., Tam, T. W., Arnason, J. T. (2011). Pharmacogenetics in potential herb-drug interactions: effects of ginseng on CYP3A4 and CYP2C9 allelic variants. In D.R. Gang (Ed.). The Biological Activity of Phytochemicals (59-65). New York, NY: Springer.